Known targets — ChEMBL curated mechanism
ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIGMAR1 known ✓ | Q99720 | 5/20 | 0.44 |
| ▸ | KCNH2 known ✓ | Q12809 | 2/20 | 0.42 |
| ▸ | ADRA2B known ✓ | P18089 | 1/20 | 0.42 |
| ▸ | ADRA2C known ✓ | P18825 | 1/20 | 0.42 |
| ▸ | SLC6A2 known ✓ | P23975 | 1/20 | 0.42 |
| ▸ | HTR2A known ✓ | P28223 | 1/20 | 0.42 |
| ▸ | SLC6A4 known ✓ | P31645 | 1/20 | 0.42 |
| ▸ | ADRA1A known ✓ | P35348 | 1/20 | 0.42 |
| ▸ | OPRK1 known ✓ | P41145 | 1/20 | 0.42 |
| ▸ | SLC6A3 known ✓ | Q01959 | 1/20 | 0.42 |
| ▸ | MAOA known ✓ | P21397 | 1/20 | 0.41 |
| ▸ | MAOB known ✓ | P27338 | 1/20 | 0.41 |
| ▸ | MMP1 known ✓ | P03956 | 1/20 | 0.40 |
| ▸ | CSNK1E | P49674 | 1/20 | 0.53 |
| ▸ | CNR2 | P34972 | 1/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | MMP2 | P08253 | 2/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL27519729 | 1.00 | CSNK1E (0.53) | CSNK1ESIGMAR1KCNH2ADRA2BADRA2C | |
| Hydrochloric Acid SCHEMBL3413577 | 1.00 | CSNK1E (0.53) | CSNK1ESIGMAR1KCNH2ADRA2BADRA2C | |
| Hydrochloric Acid SCHEMBL706077 | 1.00 | CSNK1E (0.53) | CSNK1ESIGMAR1KCNH2ADRA2BADRA2C | |
| Hydrochloric Acid SCHEMBL1416573 | 1.00 | CSNK1E (0.53) | CSNK1ESIGMAR1KCNH2ADRA2BADRA2C | |
| Hydrochloric Acid SCHEMBL5091454 | 1.00 | CSNK1E (0.53) | CSNK1ESIGMAR1KCNH2ADRA2BADRA2C | |
| Hydrochloric Acid SCHEMBL3294578 | 1.00 | CSNK1E (0.53) | CSNK1ESIGMAR1KCNH2ADRA2BADRA2C | |
| Hydrochloric Acid SCHEMBL7810565 | 1.00 | CSNK1E (0.53) | CSNK1ESIGMAR1KCNH2ADRA2BADRA2C | |
| Hydrochloric Acid SCHEMBL3409193 | 1.00 | CSNK1E (0.53) | CSNK1ESIGMAR1KCNH2ADRA2BADRA2C | |
| Hydrochloric Acid SCHEMBL8071028 | 0.98 | CSNK1E (0.51) | CSNK1ESIGMAR1KCNH2ADRA2BADRA2C | |
| Hydrochloric Acid SCHEMBL4927045 | 0.98 | CSNK1E (0.51) | CSNK1ESIGMAR1KCNH2ADRA2BADRA2C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117678607-A | Nanometer herbicide and preparation method thereof | 中国农业大学 | 2024-03-12 | — | — | CN | claimed |
| US-20170275572-A1 | COMPOSITIONS FOR PHOTODYNAMIC CONTROL OF INFECTION | PUREPURGE, INC. (US) | 2017-09-28 | — | — | US | claimed |
| EP-3193864-A1 | COMPOSITIONS FOR PHOTODYNAMIC CONTROL OF INFECTION | Purepurge, Inc. (US) | 2017-07-26 | — | — | EP | claimed |
| WO-2016039812-A1 | COMPOSITIONS FOR PHOTODYNAMIC CONTROL OF INFECTION | PUREPURGE, INC. (US) | 2016-03-17 | — | — | WO | claimed |
| WO-2014060755-A1 | CLEANING, SANITIZING AND STERILIZING PREPARATIONS | ARCIS BIOTECHNOLOGY HOLDINGS LIMITED (GB) | 2014-04-24 | — | — | WO | claimed |
| US-20100323895-A1 | CLEANING, SANITISING AND STERILISING PREPARATIONS | ARCIS BIOTECHNOLOGY HOLDINGS LIMITED (GB) | 2010-12-23 | — | — | US | claimed |
| EP-2262883-A2 | CLEANING, SANITISING AND STERILISING PREPARATIONS | Altos Medical, LLC (US) | 2010-12-22 | — | — | EP | claimed |
| WO-2009117299-A2 | CLEANING, SANITISING AND STERILISING PREPARATIONS | ALTOS MEDICAL, LLC (US) | 2009-09-24 | — | — | WO | claimed |
| US-20250056922-A1 | QUANTUM-DOT-CONTAINING COMPOSITION, LIGHT-EMITTING ELEMENT, DISPLAY DEVICE, AND METHOD FOR MANUFACTURING QUANTUM-DOT-CONTAINING COMPOSITION | Sharp Display Technology Corporation (JP) | 2025-02-13 | — | — | US | disclosed |
| WO-2023157209-A1 | QUANTUM-DOT-CONTAINING COMPOSITION, LIGHT-EMITTING ELEMENT, DISPLAY DEVICE, AND METHOD FOR MANUFACTURING QUANTUM-DOT-CONTAINING COMPOSITION | シャープディスプレイテクノロジー株式会社 | 2023-08-24 | — | — | WO | disclosed |
| US-11268022-B2 | Nanostructures with inorganic ligands for electroluminescent devices | NANOSYS, INC. (US) | 2022-03-08 | — | — | US | disclosed |
| WO-2021072255-A1 | LIGHT ACTIVATED NANOPARTICLE COMPOSITIONS AND USES THEREOF | MOLECULAR EXPRESS, INC. (US) | 2021-04-15 | — | — | WO | disclosed |
| CN-111718716-A | Nanostructures with inorganic ligands for electroluminescent devices | 纳米系统公司 | 2020-09-29 | — | — | CN | disclosed |
| US-20200299575-A1 | NANOSTRUCTURES WITH INORGANIC LIGANDS FOR ELECTROLUMINESCENT DEVICES | NANOSYS, INC. (US) | 2020-09-24 | — | — | US | disclosed |
| WO-2009117299-A2 | CLEANING, SANITISING AND STERILISING PREPARATIONS | ALTOS MEDICAL, LLC (US) | 2009-09-24 | — | — | WO | disclosed |
| US-20080275121-A1 | N-HALOGENATED AMINO ACID FORMULATIONS AND METHODS FOR CLEANING AND DISINFECTION | ALCON RESEARCH, LTD. (US) | 2008-11-06 | — | — | US | disclosed |
| US-20080275123-A1 | N-HALOGENATED AMINO ACID FORMULATIONS | ALCON RESEARCH, LTD. (US) | 2008-11-06 | — | — | US | disclosed |
| US-20080214386-A1 | Stability; easily separated from solution; surface treatment of catalyst with Group seven compound; reacting epoxide with carbon dioxide | NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) | 2008-09-04 | — | — | US | disclosed |
| EP-0402094-B1 | Process for measuring body fluid components | WAKO PURE CHEM IND LTD (JP) | 1996-08-28 | — | — | EP | disclosed |
| US-5384248-A | Process for measuring an analyte with an oxidase and an oxidizable color reagent and surfactants | WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) | 1995-01-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080275121-A1 | N-HALOGENATED AMINO ACID FORMULATIONS AND METHODS FOR CLEANING AND DISINFECTION | BCAT1, BCAT2, ASNS | SIGMAR1 3292/4885KCNH2 1406/4885ADRA2B 4700/4885 |
| US-20080275123-A1 | N-HALOGENATED AMINO ACID FORMULATIONS | BCAT1, BCAT2, SLC7A1 | SIGMAR1 1364/4885KCNH2 3768/4885ADRA2B 4152/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.